Pharmafile Logo
Pharmafocus logo
Advanced Search

Latest Feature Articles

The cutting edge of cancer research

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Cancer, feature, oncology

While immunotherapies continue to be the darling of the industry, new, innovative and sometimes seemingly fantastical research is emerging that …

Feature
8b437d43644106a4fb11aa4292aa6fbd_1

Working Life: Nicola Redfern, UK General Manager, bluebird bio

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Bluebird Bio, Interview, Working Life, pharma

How did you find your way into the pharma industry? Was it always an aspiration of yours? My mum worked …

Feature

Living with melanoma after surgery

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Cancer, melanoma, patient experience, pharma

Dr Elizabeth Walmsley was left lost when she received her melanoma diagnosis. Thankfully, through perseverance and the advice of friends …

Feature
screen_shot_2019-01-29_at_15

Beating the flu

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | flu, influenza, pharma, seqirus

On 14 January, the European Commission issued marketing approval for Flucelvax Tetra, the first cell-based, quadrivalent influenza vaccine. Pharmafocus spoke …

Feature
ai_pharmafocus

Solving the drug development problem

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | AI, drug discovery, feature, pharma, pistoia alliance

Excitement is building for the potential of AI in just about every field, but how can it address pharma’s unique …

Feature
falsified_medicines

Counterfeit drugs – countering the lies

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Counterfeit drugs, IP, counterfeit medicines, falsified medicines, intellectual property, law, legal, patent

As the Falsified Medicines Directive comes into effect in February 2019, Louis Goss fact checks ‘common sense’ claims on counterfeit …

Feature
both_together

Repurposed drugs: The Supreme Court deals a blow to patentees

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Supreme Court, drug repurposing, feature, patents, pharma

Second medical use patents protect the discovery that an existing drug is effective to treat a new condition. But, following …

Feature
mesothelioma

Pushing for progress in mesothelioma

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Cancer, mesothelioma, pharma

Mesothelioma.net reviews the wide array of latest advances in treatment and care for patients affected by the challenging cancer as …

Feature
nve00002_web

Living with Alström syndrome

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Alström syndrome, patient experience, pharma, rare disease

Kay Parkinson lived the tragedy of seeing both of her children born with an ultra-rare condition, and the elusiveness of …

Feature

How tech is powering precision treatment

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | AI, Precision Medicine, pharma, tech

As the scientific community eschews scattergun approaches and demand rises for higher-quality, targeted care, Matt Fellows explores how technologies such …

Feature
82958bfc7df1311fd17a008495fc-1456375

Pharma in 2018: Looking back, looking forward

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | 2018, Alligator Bioscience, Eisai, Gilead, Mundipharma, pharma

2018 has been a year characterised by uncertainty, but also significant leaps in research, access, and industry deals. With 2019 …

Feature
maps-2018-01-boulder-staged-lana-marcela-bruce-bryce-img_20180128_135008_preview

Psychedelic therapy: A new approach to mental health

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | LSD, MDMA, controlled substances, depression, mental health, pharma, psychotherapy

In November 2018, a Phase 2 clinical trial found that 76% of patients who underwent MDMA-assisted psychotherapy no longer had …

Feature

Working Life: Kai Gait, Senior Global Digital Director at GlaxoSmithKline

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | EU, GSK, Interview, UK, US, digital, senior global director, technology

Kai Gait, Senior Global Digital Director at GlaxoSmithKline, retraces the steps that have led him to where he is today, …

Feature

Insider Interview: The diabetes/mental health connection

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Insider Interview, Type 1 diabetes, World Diabetes Day, diabetes, feature, mental health, pharma

Michael Connellan, Head of External Affairs at the type 1 diabetes charity JDRF, discusses the results of a recent survey …

Feature
psm_v46_d168_mesial_view_of_the_human_brain

Rising to the challenge of delivering therapeutic discovery for mental disorders

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | NIHRm, Oxford, R&D, feature, investment, mental health

Professor Matthew Hotopf, Director of NIHR Maudsley Biomedical Research Centre, and Professor John R Geddes, Director of NIHR Oxford Health …

Feature
Load more Feature Articles
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026